Philippe Musette

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

P. Joly, Maud Maho‐Vaillant, C. Prost‐Squarcioni et al. · The Lancet · 2017 · 586 citations

Ritux 3, Pharmacology, Pharmacotherapy +2

A Single Cycle of Rituximab for the Treatment of Severe Pemphigus

P. Joly, Hugo Mouquet, Jean‐Claude Roujeau et al. · New England Journal of Medicine · 2007 · 460 citations

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Multiorgan Antiviral T Cell Response

D Picard, Baptiste Janela, V. Descamps et al. · Science Translational Medicine · 2010 · 382 citations

Twelve-Year Analysis of Severe Cases of Drug Reaction With Eosinophilia and Systemic Symptoms

Majed Eshki, L. Allanore, Philippe Musette et al. · Archives of Dermatology · 2009 · 286 citations

Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response

Natacha Colliou, D Picard, Frédérique Caillot et al. · Science Translational Medicine · 2013 · 238 citations